LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2015.
“Concert ended the first quarter with a strong balance sheet and the financial resources to continue advancing our portfolio of product candidates,” said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
“Concert ended the first quarter with a strong balance sheet and the financial resources to continue advancing our portfolio of product candidates,” said Roger Tung, Ph.D., President and Chief Executive Officer of Concert Pharmaceuticals.
Help employers find you! Check out all the jobs and post your resume.
